Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-06 Solaiman Shereen Chief People Officer Grant or award · Time-Based Stock Option +83,049 83,049
2026-03-14 Solaiman Shereen Chief People Officer Shares withheld for taxes −5,784 $4.66 $27K 267,801
2026-03-13 Solaiman Shereen Chief People Officer Shares withheld for taxes −8,899 $4.66 $41K 273,585
2026-03-12 Solaiman Shereen Chief People Officer Grant or award +173,196 282,484
2026-03-01 Solaiman Shereen Chief People Officer Shares withheld for taxes −1,675 $4.61 $8K 109,288
2025-03-14 Solaiman Shereen Chief People Officer Shares withheld for taxes −6,060 $10.07 $61K 110,963
2025-03-13 Solaiman Shereen Chief People Officer Grant or award +63,145 117,023
2025-03-01 Solaiman Shereen Chief People Officer Shares withheld for taxes −1,912 $10.73 $21K 53,878
2024-03-14 Solaiman Shereen Chief People Officer Grant or award +41,042 55,790
2024-03-01 Solaiman Shereen Chief People Officer Shares withheld for taxes −1,108 $22.18 $25K 14,748
2023-03-01 Solaiman Shereen Chief People Officer Grant or award +15,856 15,856

Page 1 of 1 · 11 trades